What’s Next? Five Things To Look Out For In July
Viatris May Bag Landmark FDA Interchangeable Approvals
In the month ahead, Viatris may land history-making FDA biosimilar approvals, while readers will enjoy Generics Bulletin’s usual close coverage of the quarterly financial reports.
